The total pharmaceutical market in Belgium stood at 12.6 Units of Generics in Value in 2023. From 2013 to 2023, the market showed fluctuating trends. Initial growth was seen up to 2016, peaking at 15.2, followed by a decline starting from 2017. The past five years showed an average annual decline of -2.64%. Year-on-year variations resulted in a decrease of -0.79% from 2022 to 2023. Looking forward, the market is expected to continue its decline with a forecasted 5-year average annual decrease of -0.32%.

**Future trends to watch for:**

Impact of healthcare policies and government regulations on generic pharmaceutical pricing and availability.
Innovations in biotechnology and new drug formulations that may shift focus away from generics.
Economic factors and their impact on healthcare budgets and expenditures.
Changing demographics and patient behaviors influencing pharmaceutical consumption patterns.
Potential for market consolidation and its effect on competition and pricing in the generics market.